4.7 Editorial Material

Is it time to abandon routine antibiotics for transperineal prostate biopsy?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Urology & Nephrology

Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-Analysis of Comparative Studies

Daniele Castellani et al.

Summary: Based on the systematic review, there was no significant difference in infection rate, fever, sepsis, or readmission rate after transperineal ultrasound-guided prostate biopsy between cases utilizing antibiotic prophylaxis and those not utilizing antibiotic prophylaxis.

JOURNAL OF UROLOGY (2022)

Review Urology & Nephrology

Nonantibiotic Strategies for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis

Benjamin Pradere et al.

Summary: The study identified that transperineal biopsy reduces infectious complications compared to transrectal biopsy, while rectal preparation with povidone-iodine is effective in reducing infections and hospitalization post-prostate biopsy. Other investigated nonantibiotic strategies did not have a significant impact on infection or hospitalization outcomes.

JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Evaluation of the Forsvall biopsy needle in an ex vivo model of transrectal prostate biopsy - a novel needle design with the objective to reduce the risk of post-biopsy infection

Andreas Forsvall et al.

Summary: The study compared the new Forsvall needle prototype with the standard Tru-Cut needle in simulating colonic bacterial translocation during transrectal prostate biopsy, showing a significant 96.0% reduction in bacterial translocation with the prototype needle. The findings suggest that this improved needle could potentially reduce infectious complications in prostate biopsy procedures.

SCANDINAVIAN JOURNAL OF UROLOGY (2021)

Review Oncology

Epidemiology and Prevention of Prostate Cancer

Giorgio Gandaglia et al.

Summary: Prostate cancer (PCa) rates vary profoundly worldwide, with incidence and mortality rates being highest in Northern Europe and the Caribbean, respectively. South-Central Asia has the lowest epidemiological burden. Family history, race, and hereditary syndromes are well-established risk factors for PCa. Modifiable risk factors may impact the risk of developing PCa and that of dying from the disease itself, but little evidence exists for any clear indication for prevention other than early diagnosis to reduce PCa mortality.

EUROPEAN UROLOGY ONCOLOGY (2021)

Article Urology & Nephrology

Complications After Systematic, Random, and Image-guided Prostate Biopsy

Marco Borghesi et al.

EUROPEAN UROLOGY (2017)